U.S. Urology Partners has affiliated with New Jersey Urology's central and southern divisions, enhancing its integrated urology services platform and expanding its presence into a seventh state.
Target Information
U.S. Urology Partners has officially announced the affiliation of New Jersey Urology’s central and southern divisions, thereby enhancing its integrated urology services platform. This strategic move enables U.S. Urology Partners to expand its geographic presence into a seventh state, increasing its total network to over 70 offices nationwide. The partnership brings into its fold one of the most esteemed urology groups in the country, further solidifying its stature as the largest pure-play independent provider of urologic care in the United States.
New Jersey Urology operates over 20 locations in the central and southern regions of the state and was formerly associated with Summit Health. As a partner to independent community-based urology practices, U.S. Urology Partners allows these groups to concentrate on offering exceptional care to their patients. Notably, U.S. Urology Partners had earlier secured a strategic recapitalization in April 2025, facilitated by the renowned global investment firm General Atlantic.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in New Jersey
The urology sector in New Jersey is marked by a diverse array of practices that prioritize patient care and clinical excellence. With a growing aging population and increasing awareness of urologic health issues, there has been a notable surge in demand for urolog
Similar Deals
Boston Scientific → Nalu Medical
2026
Cressey & Company LP → Paradigm Health
2025
Welsh, Carson, Anderson & Stowe → Constitution Surgery Alliance
2025
Prenetics Global Limited → 100 Bitcoin
2025
Eir Partners and New Mountain Capital → Smarter Technologies
2025
Gilead Sciences, Inc. → LEO Pharma
2025
U.S. Urology Partners
invested in
New Jersey Urology
in 2025
in a Strategic Partnership deal